News
Allergic to the cure: Researchers create a new and quicker way to detect platin drug allergies for cancer patients
nwelding • Date: March 15, 2019
Platins, the most widely used chemotherapeutic drugs, are displaying an alarming rise in drug hypersensitivity reactions much more severe than the watery eyes or runny noses associated with hay fever, which is also a Type 1, immediate hypersensitivity reaction. A Notre Dame-led team has developed a safer way of determining hypersensitivity in patients.
>Full StoryChang to receive AES Lifetime Achievement Award
nwelding • Date: March 11, 2019
Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering at the University of Notre Dame, has been selected to receive the AES Lifetime Achievement Award.
>Full StoryMatthew Webber receives American Diabetes Association’s Accelerator Award
nwelding • Date: February 19, 2019
The American Diabetes Association has announced that it will fund a $1.625 million Accelerator Award to Matthew Webber, assistant professor in the Department of Chemical and Bimolecular Engineering at the University of Notre Dame, to research and develop materials capable of sensing critical drops in blood glucose.
>Full StoryNotre Dame faculty members named to top one percent of highly cited researchers list for 2018
nwelding • Date: February 5, 2019
Professors Martin Haenggi and Prashant V. Kamat have been named to the Clarivate Analytics’ 2018 Highly Cited Researchers list.
>Full StoryMore than a decade as a chief editor, always a pioneer
nwelding • Date: January 24, 2019
In December 2018, after 12 years of leadership, Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering at the University of Notre Dame, stepped down as the founding and chief editor of Biomicrofluidics.
>Full Story
